Loading…

Isotopically Labeled Desthiobiotin Azide (isoDTB) Tags Enable Global Profiling of the Bacterial Cysteinome

Rapid development of bacterial resistance has led to an urgent need to find new druggable targets for antibiotics. In this context, residue‐specific chemoproteomic approaches enable proteome‐wide identification of binding sites for covalent inhibitors. Described here are easily synthesized isotopica...

Full description

Saved in:
Bibliographic Details
Published in:Angewandte Chemie 2020-02, Vol.132 (7), p.2851-2858
Main Authors: Zanon, Patrick R. A., Lewald, Lisa, Hacker, Stephan M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rapid development of bacterial resistance has led to an urgent need to find new druggable targets for antibiotics. In this context, residue‐specific chemoproteomic approaches enable proteome‐wide identification of binding sites for covalent inhibitors. Described here are easily synthesized isotopically labeled desthiobiotin azide (isoDTB) tags that shortened the chemoproteomic workflow and allowed an increased coverage of cysteines in bacterial systems. They were used to quantify 59 % of all cysteines in essential proteins in Staphylococcus aureus and enabled the discovery of 88 cysteines that showed high reactivity, which correlates with functional importance. Furthermore, 268 cysteines that are engaged by covalent ligands were identified. Inhibition of HMG‐CoA synthase was verified and will allow addressing the bacterial mevalonate pathway through a new target. Overall, a broad map of the bacterial cysteinome was obtained, which will facilitate the development of antibiotics with novel modes‐of‐action. Zielgerichtete Suche: Isotopenmarkierte Desthiobiotinazid(isoDTB)‐Tags wurden auf einfache Weise synthetisiert und ermöglichten die aminosäurespezifische Untersuchung des Cysteinoms in S. aureus. Auf diese Weise wurden 268 Cysteine identifiziert, die mit kovalenten Inhibitoren adressiert werden können und damit als Zielstrukturen für die Entwicklung von Antibiotika mit neuartigen Wirkungsweisen erforscht werden können.
ISSN:0044-8249
1521-3757
DOI:10.1002/ange.201912075